Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism M3 receptor agonists(Muscarinic acetylcholine receptor M3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bronchitis, Chronic | Phase 2 | CN | 09 Aug 2024 | |
Bronchitis, Chronic | Phase 2 | CN | 09 Aug 2024 | |
Pulmonary Emphysema | Phase 2 | CN | 09 Aug 2024 | |
Pulmonary Emphysema | Phase 2 | CN | 09 Aug 2024 | |
Asthma | Preclinical | US | 01 Apr 2015 | |
Pulmonary Disease, Chronic Obstructive | Preclinical | US | 01 May 2014 |